Stakeholders urge wide berth for CBD

Europe-based cannabidiol (CBD) stakeholders have launched an information-gathering effort to bolster their arguments aimed at keeping CBD off international drug schedules. The initiative is in anticipation of a World Health Organization (WHO) expert committee meeting in November that is to review CBD and 15 other psycho-active substances. Full story on HempToday.


Related Posts